2 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow SARS-CoV-2: new trials by email Literature Review of SARS-CoV-2 trials Research Report on SARS-CoV-2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age mRNA-1283, mRNA-1273 - SARS-CoV-2 | Phase 2 | Recruiting | ModernaTX, Inc. | 300 | 2026-09-04 | 2026-10-29 |
| Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) Placebo comparator, PRS CK STORM - SARS-CoV-2, Influenza, Human | Phase 1 / Phase 2 | Recruiting | PEACHES BIOTECH | 50 | 2024-10-02 | 2026-06-10 |
COVID-19 (2) · Coronavirus Infections (1) · Cytokine Release Syndrome (1) · Influenza, Human (1) · Lung Diseases (1) · Pneumonia (1) · Respiratory Distress Syndrome (1) · Respiratory Syncytial Virus Infections (1) · Systemic Inflammatory Response Syndrome (1) · Virus Diseases (1)
Coronaviridae Infections (2) · Infections (2) · Nidovirales Infections (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Coronavirus Infections (1) · Inflammation (1) · Lung Diseases (1) · Mononegavirales Infections (1) · Orthomyxoviridae Infections (1) · Paramyxoviridae Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
2019-nCoV Vaccine mRNA-1273 (1) · Saline Solution (1)
ModernaTX, Inc. (1) · PEACHES BIOTECH (1)
Argentina (1) · Dominican Republic (1) · Mexico (1) · Panama (1) · Puerto Rico (1) · Spain (1) · United States (1)
2023 (1)